Olivier Bonnot1, Clarissa S Gama2, Eugen Mengel3, Mercè Pineda4, Marie T Vanier5, Louise Watson6, Marie Watissée7, Barbara Schwierin7, Marc C Patterson8. 1. a Department of Child and Adolescent Psychiatry , University and CHU of Nantes , Nantes , France. 2. b Laboratory of Molecular Psychiatry , Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul , Porto Alegre , Brazil. 3. c Paediatric and Adolescent Medical Centre , Johannes Gutenberg University , Mainz , Germany. 4. d Department of Neuropediatrica , Fundacio Hospital Sant Joan de Déu , Barcelona , Spain. 5. e Metabolomic and Metabolic Diseases , INSERM Unit 820 , Lyon , France. 6. f Explore-epi Ltd , Norfolk , UK. 7. g Actelion Pharmaceuticals Ltd , Allschwil , Switzerland. 8. h Pediatric and Adolescent Medicine , Mayo Clinic , Rochester , MN , USA.
Abstract
Objectives: Niemann-Pick disease type C (NP-C) is a rare inherited neurovisceral disease that should be recognised by psychiatrists as a possible underlying cause of psychiatric abnormalities. This study describes NP-C patients who had psychiatric manifestations at enrolment in the international NPC Registry, a unique multicentre, prospective, observational disease registry. Methods: Treating physicians' data entries describing psychiatric manifestations in NPC patients were coded and grouped by expert psychiatrists. Results: Out of 386 NP-C patients included in the registry as of October 2015, psychiatric abnormalities were reported to be present in 34% (94/280) of those with available data. Forty-four patients were confirmed to have identifiable psychiatric manifestations, with text describing these psychiatric manifestations. In these 44 patients, the median (range) age at onset of psychiatric manifestations was 17.9 years (2.5-67.9; n = 15), while the median (range) age at NP-C diagnosis was 23.7 years (0.2-69.8; n = 34). Almost all patients (43/44; 98%) had an occurrence of ≥1 neurological manifestation at enrolment. Conclusions: These data show that substantial delays in diagnosis of NP-C are long among patients with psychiatric symptoms and, moreover, patients presenting with psychiatric features and at least one of cognitive impairment, neurological manifestations, and/or visceral symptoms should be screened for NP-C.
Objectives:Niemann-Pick disease type C (NP-C) is a rare inherited neurovisceral disease that should be recognised by psychiatrists as a possible underlying cause of psychiatric abnormalities. This study describes NP-Cpatients who had psychiatric manifestations at enrolment in the international NPC Registry, a unique multicentre, prospective, observational disease registry. Methods: Treating physicians' data entries describing psychiatric manifestations in NPC patients were coded and grouped by expert psychiatrists. Results: Out of 386 NP-Cpatients included in the registry as of October 2015, psychiatric abnormalities were reported to be present in 34% (94/280) of those with available data. Forty-four patients were confirmed to have identifiable psychiatric manifestations, with text describing these psychiatric manifestations. In these 44 patients, the median (range) age at onset of psychiatric manifestations was 17.9 years (2.5-67.9; n = 15), while the median (range) age at NP-C diagnosis was 23.7 years (0.2-69.8; n = 34). Almost all patients (43/44; 98%) had an occurrence of ≥1 neurological manifestation at enrolment. Conclusions: These data show that substantial delays in diagnosis of NP-C are long among patients with psychiatric symptoms and, moreover, patients presenting with psychiatric features and at least one of cognitive impairment, neurological manifestations, and/or visceral symptoms should be screened for NP-C.
Entities:
Keywords:
Niemann-Pick disease type C; Psychosis; genetics; registry; schizophrenia
Authors: Rohini Sidhu; Yawo Mondjinou; Mingxing Qian; Haowei Song; Arun Babu Kumar; Xinying Hong; Fong-Fu Hsu; Dennis J Dietzen; Nicole M Yanjanin; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Michael H Gelb; Jean E Schaffer; Daniel S Ory; Xuntian Jiang Journal: J Lipid Res Date: 2019-06-14 Impact factor: 5.922
Authors: Thomas Rego; Sarah Farrand; Anita M Y Goh; Dhamidhu Eratne; Wendy Kelso; Simone Mangelsdorf; Dennis Velakoulis; Mark Walterfang Journal: CNS Drugs Date: 2019-02 Impact factor: 5.749
Authors: Rohini Sidhu; Pamela Kell; Dennis J Dietzen; Nicole Y Farhat; An Ngoc Dang Do; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Janine Reunert; Thorsten Marquardt; Roberto Giugliani; Charles M Lourenço; Olaf Bodamer; Raymond Y Wang; Ellen Plummer; Jean E Schaffer; Daniel S Ory; Xuntian Jiang Journal: Mol Genet Metab Date: 2020-01-22 Impact factor: 4.204
Authors: Marc C Patterson; Eugen Mengel; Marie T Vanier; Patrick Moneuse; Daniel Rosenberg; Mercedes Pineda Journal: Orphanet J Rare Dis Date: 2020-04-25 Impact factor: 4.123
Authors: Alessio Colombo; Lina Dinkel; Stephan A Müller; Laura Sebastian Monasor; Martina Schifferer; Ludovico Cantuti-Castelvetri; Jasmin König; Lea Vidatic; Tatiana Bremova-Ertl; Andrew P Lieberman; Silva Hecimovic; Mikael Simons; Stefan F Lichtenthaler; Michael Strupp; Susanne A Schneider; Sabina Tahirovic Journal: Nat Commun Date: 2021-02-24 Impact factor: 17.694